Drug Shortage Report for TRIZIVIR

Last updated on 2021-12-08 History
Report ID 90619
Drug Identification Number 02244757
Brand name TRIZIVIR
Common or Proper name abacavir (as abacavir sulfate), lamivudine and zidovudine tablets
Company Name VIIV HEALTHCARE ULC
Market Status CANCELLED POST MARKET
Active Ingredient(s) ZIDOVUDINE ABACAVIR LAMIVUDINE
Strength(s) 300MG 300MG 150MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 60's
ATC code J05AR
ATC description DIRECT ACTING ANTIVIRALS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2019-08-23
Estimated end date Unknown
Actual end date 2019-09-17
Shortage status Resolved
Updated date 2021-12-08
Company comments This product has been discontinued.
Health Canada comments
Tier 3 Status No
Company contact information 1-877-393-8448

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2019-08-02 English Compare
v2 2019-08-02 French Compare
v3 2019-08-02 French Compare
v4 2019-08-16 English Compare
v5 2019-08-16 French Compare
v6 2019-08-23 English Compare
v7 2019-08-23 French Compare
v8 2019-08-24 English Compare
v9 2019-09-18 English Compare
v10 2019-09-18 French Compare
v11 2021-12-08 English Compare
v12 2021-12-08 French Compare
v13 2021-12-08 English Compare
v14 2021-12-08 French Compare

Showing 1 to 14 of 14